Skip to main content
logo
Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2024

Agile Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
Period Ending
Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20 Dec '19 Sep '19
Net Income
-15.86-7.79-14.47-13.93-19.06-20.42-25.41-41.01-51.86-64.32-71.07-69.16-67.91-61.1-51.85-40.25-29.16-21.82-18.61-16.4
Depreciation & Amortization
0.40.40.390.380.541.041.532.022.312.272.221.781.280.780.280.190.170.160.160.13
Other Amortization
0.610.891.061.171.761.861.972.032.462.081.661.26--1.34-----
Loss (Gain) From Sale of Assets
----11.1211.1211.1211.12------------
Stock-Based Compensation
1.621.821.981.942.042.232.492.843.193.363.343.182.942.942.822.522.251.891.762.15
Other Operating Activities
2.35-8.48-5.96-10.24-20.05-25.43-25.12-22.09-7.8-0.331.51.861.761.68-0.90.450.1--0.09
Change in Accounts Receivable
-0.09-1.69-0.020.19-2.37-1.46-1.84-2.4-0.92-1.34-0.67-1.31-1.17-0.32-0.87-----
Change in Inventory
-4.06-2.34-2.21-0.61-0.590.09-0.76-2.25-4.2-6.43-6.29-4.88-3.46-1.59------
Change in Accounts Payable
13.665.027.695.16-3.013.3-0.630.534.354.95.22.515.35.933.645.464.811.51.38-0.65
Change in Income Taxes
-----4.68----4.68----------
Change in Other Net Operating Assets
-0.351.711.954.631.250.20.71-1.79-0.41-0.8-1.1-1.17-1.41-2.4-2.67-2.05-1.52-0.45-0.39-0.7
Operating Cash Flow
-1.71-10.46-9.58-11.31-28.38-22.79-35.95-51.01-52.88-65.29-65.2-65.93-62.67-54.1-47.31-33.24-23-18.61-15.69-15.56
Operating Cash Flow Growth (YoY)
--------------------

Investing Activities

Fiscal Quarter
Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
Period Ending
Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20 Dec '19 Sep '19
Capital Expenditures
------0.01-0.13-0.19-0.25-0.32-0.27-0.27-0.28-0.26-0.35-0.36-0.32-0.26-0.1-0.03
Investment in Securities
--------523.4739.7347.3142.21-24.08-40.34-47.92-47.82---
Investing Cash Flow
------0.01-0.13-0.194.7523.1539.4647.0441.93-24.34-40.69-48.29-48.14-0.26-0.1-0.03

Financing Activities

Fiscal Quarter
Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
Period Ending
Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20 Dec '19 Sep '19
Long-Term Debt Issued
--------------20-----
Total Debt Issued
--------------20202020--
Long-Term Debt Repaid
---1.35----17.38-------------
Total Debt Repaid
-2.68-2.96-1.35-1.08-12.89-12.6-17.38-17.15-5-5----------5.94
Net Debt Issued (Repaid)
-2.68-2.96-1.35-1.08-12.89-12.6-17.38-17.15-5-5----20202020--5.94
Issuance of Common Stock
4.4511.618.249.1231.0236.0935.4355.6335.9230.2930.429.467.40.9849.0468.3881.0682.342.4222.97
Other Financing Activities
---------------1.06-1.06-1.06-1.06--
Financing Cash Flow
1.778.656.898.0418.1323.4822.1842.635.0529.4230.429.467.40.9867.9987.32100101.2442.4217.03

Net Cash Flow

Fiscal Quarter
Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
Period Ending
Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20 Dec '19 Sep '19
Miscellaneous Cash Flow Adjustments
---0----------------
Net Cash Flow
0.06-1.81-2.69-3.27-10.240.69-13.9-8.59-13.09-12.724.68-9.43-13.33-77.46-20.025.7928.8682.3726.631.44

Free Cash Flow

Fiscal Quarter
Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
Period Ending
Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20 Dec '19 Sep '19
Free Cash Flow
-1.71-10.46-9.58-11.31-28.38-22.8-36.08-51.19-53.14-65.61-65.47-66.2-62.95-54.36-47.66-33.6-23.32-18.87-15.79-15.59
Free Cash Flow Growth (YoY)
--------------------
Free Cash Flow Margin
-7.91%-48.65%-48.88%-56.61%-173.95%-176.24%-331.50%-609.31%-794.62%-1141.82%-1596.46%-1984.32%-3070.54%-6283.82%-6363.68%-----
Free Cash Flow Per Share
-0.39-3.39-4.44-6.98-26.63-35.36-83.48-213.53-821.76-1234.20-1348.92-1480.85-1433.88-1243.42-1125.69-855.80-665.12-636.90-638.74-736.67
Levered Free Cash Flow
3.95-6.11-3.68-4.36-19.91-9.47-23.95-32.97-30.56-41.37-37.28-40.55-37.7-31.74-26.4-17.69-12.92-10.86-8.79-9.34
Unlevered Free Cash Flow
3.85-6.25-3.86-4.56-20.29-9.66-23.96-32.69-30.71-41.03-36.5-39.43-35.38-29.47-25.8-16.31-12.1-10.61-8.79-9.24

Additional Metrics

Fiscal Quarter
Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
Period Ending
Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20 Jun '20 Mar '20 Dec '19 Sep '19
Cash Interest Paid
0.310.310.360.360.360.81.161.682.12.252.382.382.392.392.11.50.90.3-0.75
SEC Filings: 10-K · 10-Q